Alan Herosian

Currently Director, Corporate Alliances & Development, Duke University Medical Center, Office of Corporate and Venture Development. Responsibilities include business development and interaction with big pharma and biotech involved in healthcare and life sciences. Primary objectives include commercialization of Duke developed technologies, forging alliances in basic and clinical research, new venture creation with Duke assets, and creating models of partnership with industry to satisfy mutual agendas. Also responsible for advancing Duke Medical Center’s philanthropic initiatives with industry.

Prior experience includes: Embrex, Inc., SmithKline Beckman Corporation, and various product marketing and general management positions including five(5) years P&L operations responsibility in Europe/Africa/Middle East, Merck & Co., Inc. 

While at Embrex, developed business plan to secure financing for a start-up biotechnology company to develop and commercialize unproven, but potentially revolutionary, cutting edge technologies blending unique drug deliver concepts with biologically active agents. Secured and linked enabling technologies from public and private sources through acquisition and/or license. Established strong proprietary positions for key “core” technologies of the business.

At SmithKline Beckman, directed commercial development, established overall strategic plan and ensured implementation of launch activities of major new product for veterinary use in over 15 countries overseas.